Optimal Designs for Pharmacokinetic Studies of Oral Artesunate in Malaria Patients
Author Information
Author(s): Kris M Jamsen, Stephen B Duffull, Joel Tarning, Niklas Lindegardh, Nicholas J White, Julie A Simpson
Primary Institution: Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne
Hypothesis
Optimal design methodology can improve the precision of pharmacokinetic parameter estimates in population studies of oral artesunate.
Conclusion
The proposed sampling designs are robust and efficient for future pharmacokinetic studies of oral artesunate.
Supporting Evidence
- The optimal designs resulted in acceptable precision of the pharmacokinetic parameters.
- Sampling windows were determined to maximize information while minimizing patient discomfort.
- Three to four blood samples per patient were deemed sufficient for parameter estimation.
Takeaway
This study helps figure out the best times to take blood samples from malaria patients to understand how well a medicine works.
Methodology
Optimal designs were derived using software based on pharmacokinetic models and sampling constraints identified through a survey of malaria researchers.
Potential Biases
Potential bias due to reliance on limited data from specific populations.
Limitations
The designs were based on models from Asian populations, which may not fully represent African populations.
Participant Demographics
Included non-pregnant adults, children, and pregnant women.
Statistical Information
Confidence Interval
95%
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website